Thu, January 30, 2025

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Almadex Minerals Ltd. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Nevada Canyon Gold Corp. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of CytoDyn Inc. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Evaxion Biotech A/S in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Dogwood Therapeutics, Inc. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Vincerx Pharma, Inc. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Bakkt Holdings, Inc. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Echo Defense Projects Inc. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of BioAdaptives, Inc. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Tapinator, Inc. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Hong Kong Technology Venture Company Limited in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Alpha Tau Medical Ltd. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of Foremost Lithium Resource & Technology Ltd. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of NeuroSense Therapeutics Ltd. in recent trading

by: WOPRAI

As of Jan 30th, 2025, there has been substantial selling of in recent trading

by: Investopedia

Is Warren Buffett Right That the Stock Market Is Like a Casino? What Investors Need To Know

Warren Buffett's claim that the stock market is increasingly like a casino is supported by research. However, there are ways to shift the odds in your favor.
Wed, January 29, 2025

by: MSN

International Paper Company (IP): Investing in Renewable Packaging Innovation

We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a look at where International Paper Company (NYSE:IP) stands against other non-tech AI opportunities amid DeepSeek selloff.

by: MSN

UPS's SWOT analysis: global logistics giant navigates shifting stock landscape

United Parcel Service, Inc. (NYSE:UPS), the world's largest package delivery company, continues to navigate a complex and evolving global logistics landscape. With a vast network spanning over 220 countries and territories,

by: MSN

DeepSeek and AI's Efficiency Era

Why software prowess and efficiency will be the major themes for AI in 2025. What to focus on when affected big tech companies report earnings this week. Then, Motley Fool Analyst David Meier interviews John Zahurancik,

by: MSN

Why Novo Nordisk A/S (NVO) Is the Best Blue Chip Stock to Buy Under $100?

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best blue chip stocks to buy under $100.

by: MSN

Looking for a bargain? 4 ways to tell if a stock is undervalued

Though you may not think of it the same way, investing in the stock market is no different. While people are typically excited to see their favorite items on sale at the grocery store, they can often be less enthusiastic when they see stock prices fall.

by: MSN

Investing Lessons from Mark Cuban Anyone Can Use

Billionaire Mark Cuban has plenty of advice for the average person who wants to get rich and retire—but they may not want to hear it. Cuban made his money by building and selling tech companies and becoming an active stock trader.

by: Kiplinger

Stock Market Today: Stocks Jump Around on Fed Day

Fed Chair Jerome Powell plays it as straight as possible while President Trump and threats to the AI rally abound.

by: AOL

3 ETFs Every Baby Boomer Should Buy and Hold Forever

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Retirement should be stress-free. You shouldn't have to worry about generating extra income.

by: MSN

US stocks, Nvidia shares steady after Chinese AI shock

US stocks and shares in chip-making giant Nvidia on Tuesday clawed back some of their losses following a sell-off triggered by the sudden success of Chinese artificial intelligence firm DeepSeek. General Motors reported a $3-billion quarterly loss Tuesday due to costs from restructuring a Chinese venture,

by: MSN

Retire Rich With 2 Resilient Growth Stocks

Retiring rich and healthy is almost every Canadian's dream, but even though many of them save a significant sum, few can grow it into a sizable nest egg. The post Retire Rich With 2 Resilient Growth Stocks appeared first on The Motley Fool Canada.

by: Kiplinger

ASML Stock Remains a Strong Buy After Earnings

ASML stock rallied after the semiconductor supplier beat fourth-quarter expectations. Here's what you need to know.

by: MSN

5 Building Products Stocks Navigating Industry Challenges

The Zacks Building Products - Miscellaneous industry continues to navigate challenges stemming from a weak real estate market and inflation-driven consumer uncertainty. The real estate market remained weak due to high mortgage rates,

by: MSN

Cantor Fitzgerald sees upside in select biotech stocks

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, Cantor Fitzgerald highlighted a positive outlook despite broader market uncertainties.

by: MSN

Mutual Funds: These 7 large-cap funds gave high returns in the past 10 years. Do you own any?

There are over half a dozen large-cap mutual fund schemes which have delivered more than 11 per cent CAGR return in the past one decade. We list them here.

by: AOL

Ask the experts: I just got married. What investing decisions should my spouse and I consider?

You and your spouse might align on goals but still disagree on the best investments. For example, one partner might shy away from stocks, preferring safer investments, while the other is more inclined to pick an aggressive, high-growth strategy.

by: bnnbloomberg

Goldman Strategists Say Tech Selloff Was No Bear Market Signal

The tech-led selloff in US equities at the start of this week was just a blip, given the positive outlook for the economy, according to Goldman Sachs Group Inc. strategists.

by: WOPRAI

Short squeeze is starting in shares of FMNB at $14.17, after crossing above the $13.937 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of FIBK at $33.44, after crossing above the $33.276 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ENVB at $4.22, after crossing above the $2.481 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CSBB at $37.98, after crossing above the $37.522 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BCTXF at $5.345, after crossing above the $4.517 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BCTX at $5.345, after crossing above the $4.885 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ASCUF at $1.175, after crossing above the $1.145 Trigger Price

by: MSN

The Secret to Picking Top-Performing US Stocks

Planning to invest in US stocks and engage with some of the world's most influential companies like Apple, NVIDIA and Amazon? Adding US stocks offers numerous benefits, such as access to a mature and diverse market,

by: WOPRAI

Short squeeze is starting in shares of TH at $10.04, after crossing above the $10.017 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of KVUE at $21.48, after crossing above the $21.472 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CUBE at $42.06, after crossing above the $41.991 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ASMLF at $744, after crossing above the $720.468 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ANGO at $12.98, after crossing above the $12.61 Trigger Price

by: Oregonian

Roth IRA vs. brokerage account: What's the difference?

Roth IRAs have tax advantages that make them useful for long-term savings goals such as retirement. Brokerage accounts have fewer rules and more flexibility.

by: WOPRAI

Short squeeze is starting in shares of ROCK at $62.1, after crossing above the $62.008 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of QGEN at $45.27, after crossing above the $45.185 Trigger Price

Why Novo Nordisk A/S (NVO) Is the Best Blue Chip Stock to Buy Under $100?

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best blue chip stocks to buy under $100.

The article from MSN Money discusses why Novo Nordisk A/S (NVO) is considered the best blue-chip stock to buy under $100. It highlights several key points: Novo Nordisk, a Danish multinational pharmaceutical company, is renowned for its focus on diabetes care, obesity, and other chronic diseases. The company's stock has shown consistent growth, supported by its strong product pipeline, particularly with drugs like Ozempic and Wegovy, which have seen significant market success. The article points out that despite its high valuation, Novo Nordisk's forward-looking earnings growth, robust financial health, and a history of increasing dividends make it an attractive investment. Additionally, the company's strategic expansion into new markets and its commitment to research and development further solidify its position as a stable and promising investment for those looking at blue-chip stocks within this price range.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/savingandinvesting/why-novo-nordisk-a-s-nvo-is-the-best-blue-chip-stock-to-buy-under-100/ar-AA1y52bJ